Amundi Asset Management US’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $679K | Buy |
5,570
+70
| +1% | +$8.53K | ﹤0.01% | 1288 |
|
|
2020
Q4 | $842K | Hold |
5,500
| – | – | ﹤0.01% | 1238 |
|
|
2020
Q3 | $460K | Hold |
5,500
| – | – | ﹤0.01% | 1255 |
|
|
2020
Q2 | $404K | Hold |
5,500
| – | – | ﹤0.01% | 1265 |
|
|
2020
Q1 | $233K | Hold |
5,500
| – | – | ﹤0.01% | 1295 |
|
|
2019
Q4 | $335K | Hold |
5,500
| – | – | ﹤0.01% | 1367 |
|
|
2019
Q3 | $225K | Buy |
5,500
+1,200
| +28% | +$49.1K | ﹤0.01% | 1415 |
|
|
2019
Q2 | $203K | Hold |
4,300
| – | – | ﹤0.01% | 1449 |
|
|
2019
Q1 | $154K | Sell |
4,300
-100
| -2% | -$3.58K | ﹤0.01% | 1458 |
|
|
2018
Q4 | $126 | Buy |
4,400
+1,200
| +38% | +$34 | ﹤0.01% | 1446 |
|
|
2018
Q3 | $142K | Hold |
3,200
| – | – | ﹤0.01% | 1446 |
|
|
2018
Q2 | $188K | Buy |
3,200
+400
| +14% | +$23.5K | ﹤0.01% | 1428 |
|
|
2018
Q1 | $128K | Sell |
2,800
-400
| -13% | -$18.3K | ﹤0.01% | 1383 |
|
|
2017
Q4 | $75K | Buy |
+3,200
| New | +$75K | ﹤0.01% | 1447 |
|